Company Data

Pharvaris N.V.

Ticker
PHVS
Current Price
$29.365 21.75%
Market Cap
$1.6B
Price Target
Refer to Report
Volume
3.5M
52wk Range
$11.51 - $29.665
Advanced Market Data

Overview

Pharvaris NV is a clinical-stage company. It is focused on the discovery and development of novel oral bradykinin B2-receptor antagonists for the treatment of hereditary angioedema (HAE) and other bradykinin B2-receptor-mediated indications.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy